Octreotide Lp Teva

Octreotide, the active ingredient in Octreotide Lp Teva, is a somatostatin analog presented as a formulation for subcutaneous use. It treats hormone‑secreting tumours and related endocrine disorders in adults.

GNH USA supplies Octreotide Lp Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Octreotide is a synthetic analogue of somatostatin that acts on neuroendocrine pathways. It is employed in several endocrine‑related conditions: - Acromegaly: reduces growth hormone and IGF‑1 levels, helping control disease activity. - Carcinoid syndrome: lessens flushing and diarrhoea by inhibiting serotonin release. - VIPoma and other functional neuroendocrine tumours: controls severe watery diarrhoea and electrolyte loss. - Prevention of postoperative pancreatic fistula: lowers pancreatic secretions after major abdominal surgery. - Diagnostic imaging: used off‑label to enhance somatostatin receptor scintigraphy (SRS) imaging quality.

Octreotide may cause a range of adverse reactions, most of which are mild to moderate in intensity.

Common Side Effects: - Nausea and vomiting: mild gastrointestinal upset. - Abdominal pain or cramps: intermittent discomfort. - Diarrhoea or constipation: altered bowel habits. - Injection site reactions: redness, swelling or bruising. - Headache: transient cranial discomfort. - Hyperglycaemia or hypoglycaemia: fluctuations in blood glucose.

Serious or Rare Side Effects: - Gallbladder sludge or gallstones: biliary stasis leading to cholelithiasis. - Pancreatitis: inflammation of the pancreas. - Severe hypoglycaemia: especially in patients with insulinoma. - Cardiac arrhythmias: irregular heart rhythm. - Anaphylactic reactions: rare systemic hypersensitivity.

Octreotide should be used with careful clinical monitoring and adherence to safety guidelines.

- Assess patient history for cardiovascular disease: monitor heart rate and rhythm. - Monitor blood glucose levels: adjust diabetic therapy as needed. - Evaluate liver function tests periodically: detect potential hepatobiliary effects. - Review thyroid status in patients with thyroid disorders: watch for altered hormone levels. - Use caution in patients with gallbladder disease : risk of biliary complications. - Store at room temperature: keep in the original packaging , protect from moisture and light .

The pharmacological     ... ... ... ... ... ... ... ... ... ...  .... .

Major Interactions (  ":[ -  ");"  "  ewline ");" "". """  """. \